Trinity Biotech plc ADS/$TRIB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Trinity Biotech plc ADS
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
Ticker
$TRIB
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Bray, Ireland
Employees
401
ISIN
US8964385046
Website
TRIB Metrics
BasicAdvanced
$11M
-
-$1.77
0.87
-
Price and volume
Market cap
$11M
Beta
0.87
52-week high
$0.89
52-week low
$0.48
Average daily volume
54K
Financial strength
Current ratio
1.281
Quick ratio
0.616
Long term debt to equity
-279.324
Total debt to equity
-286.416
Interest coverage (TTM)
-1.15%
Profitability
EBITDA (TTM)
-11.839
Gross margin (TTM)
34.83%
Net profit margin (TTM)
-51.64%
Operating margin (TTM)
-22.26%
Effective tax rate (TTM)
-1.58%
Revenue per employee (TTM)
$150,000
Management effectiveness
Return on assets (TTM)
-10.53%
Return on equity (TTM)
105.58%
Valuation
Price to revenue (TTM)
0.167
Price to book
-0.29
Price to tangible book (TTM)
-0.09
Price to free cash flow (TTM)
-0.721
Free cash flow yield (TTM)
-138.67%
Free cash flow per share (TTM)
-79.37%
Growth
Revenue change (TTM)
8.31%
Earnings per share change (TTM)
-41.61%
3-year revenue growth (CAGR)
-8.80%
10-year revenue growth (CAGR)
-5.19%
3-year earnings per share growth (CAGR)
103.73%
10-year earnings per share growth (CAGR)
-6.74%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Trinity Biotech plc ADS stock?
Trinity Biotech plc ADS (TRIB) has a market cap of $11M as of June 20, 2025.
What is the P/E ratio for Trinity Biotech plc ADS stock?
The price to earnings (P/E) ratio for Trinity Biotech plc ADS (TRIB) stock is 0 as of June 20, 2025.
Does Trinity Biotech plc ADS stock pay dividends?
No, Trinity Biotech plc ADS (TRIB) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Trinity Biotech plc ADS dividend payment date?
Trinity Biotech plc ADS (TRIB) stock does not pay dividends to its shareholders.
What is the beta indicator for Trinity Biotech plc ADS?
Trinity Biotech plc ADS (TRIB) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.